Vision For Digital Health Transformation

رؤية الوزارة حول التحول الرقمي للقطاع الصحي

Foreword by the Minister of Health

In the following pages, we reveal a compelling vision for the future of digital health in Lebanon—an innovative blueprint developed through collaborative, forward-thinking, and inclusive efforts. With the recognition of digital technology as an integral driver of healthcare improvement, the Ministry of Public Health (MoPH) has been at the forefront, rallying essential stakeholders and orchestrating strategic discussions aimed at redefining our healthcare landscape.

This grand vision is grounded in the National Health Strategy, launched by the MoPH in January 2023. Recognizing the importance of digital health transformation, this strategy identified it as a crucial pillar. From this sturdy foundation, the Digital Health Retreat was organized on May 18, 2023. This retreat acted as a catalyst, creating an arena for stakeholders to identify the challenges and opportunities present in Lebanon's digital health ecosystem. A consensus was reached, emphasizing the pressing need for a consolidated vision that enables our healthcare system and augments health outcomes for our people.

Our healthcare sector, while resilient, faces its fair share of hurdles. With this understanding, and building upon the significant investments in digital health stipulated by the National Health Strategy, our vision aims to utilize digital solutions to overcome these barriers, thereby enriching healthcare outcomes. This is a vision of synergy, empowerment, and readiness for the evolving landscape of healthcare.

Our transformative vision transcends policy constraints. It establishes a detailed blueprint for developing a resilient digital health infrastructure. These strategies encompass a multitude of aspects—from digital platforms and mobile applications to health information exchange systems and more.
The implications of this digital health transformation are immense. From improved care coordination to enhanced population health outcomes, this vision for digital health, inherent in the National Health Strategy, is poised to serve as a guiding beacon for our future. Our journey begins here, and we invite you to join us as we map the pathway for a healthier Lebanon. Together, we can transform this vision into reality.

Vision for Digital Health Transformation

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A12AA03	CALCIUM GLUCONATE S.A.L.F	G	Calcium gluconate monohydrate - 10%	10%	Injectable solution	389,714 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 500mg/50ml	500mg/50ml	Injectable solution	L.L
H01BB03	CARBETOCINA GP-PHARM	G	Carbetocin - 100mcg	100mcg	Injectable solution	9,041,227 L.L
J01XB01	COLISTIN/NORMA	G	Colistimethate Sodium - 1MIU	1MIU	Injectable solution	872,154 L.L
N05AF05	CLOPIXOL DEPOT	B	Zuclopenthixol decanoate - 200mg/ml	200mg/ml	Injectable solution	512,004 L.L
N05AF05	CLOPIXOL ACUPHASE	B	Zuclopenthixol acetate - 100mg/2ml	100mg/2ml	Injectable solution	857,372 L.L
L01BC01	CYTU	G	Cytarabine - 1000mg/10ml	1000mg/10ml	Injectable solution	2,230,779 L.L
L04AB04	CINNORA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	14,817,734 L.L
A03FA01	CHLORHYDRATE DE METOCLOPRAMIDE RENAUDIN	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	530,818 L.L
B05XA07	CALCIUM CHLORIDE	G	Calcium chloride - 10g/100ml	10g/100ml	Injectable solution	5,436,771 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE C	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.33g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 204.54g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE D	G	Potassium chloride - 5.215g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE E	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 7.00g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 205.49g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE F	G	Potassium chloride - 3.914g/l, Magnesium chloride, 6H2O - 3.558g/l, Calcium chloride, 2H2O - 7.719g/l, Acetic acid 100% - 6.010ml/l, Sodium chloride - 208.631g/l		Injectable solution	L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	102,120,767 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE SG	G	Potassium chloride - 3.92g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS L	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LM	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:111.5 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS2	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.5 mmol/l, Sodium acetate - Cl-:111 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTIONFOR HEMODIALYSIS TYPE A	G	Hemodialytics, concentrates -		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE B+	G	Hemodialytics, concentrates -		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE J	G	Hemodialytics, concentrates -		Injectable solution	L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 100mg/10ml	100mg/10ml	Injectable solution	47,779,251 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 500mg/50ml	500mg/50ml	Injectable solution	218,656,548 L.L
L01CA02	CELLCRISTIN	G	Vincristine sulfate - 1mg/ml	1mg/ml	Injectable solution	1,443,287 L.L
J01DE01	CEFIPEX 500 BENTA	G	Cefepime (hydrochloride) - 500mg	500mg	Injectable solution	545,216 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	L.L

...